Despite a seemingly unattractive ROE, HangzhouS MedTech's im...
Despite a seemingly unattractive ROE, HangzhouS MedTech's impressive net income growth and operational efficiency suggest strong investment potential. Expectations hint at sustained growth rate driven by high reinvestment, despite the low ROE.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000002761d2abc18976.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment